Fertility Preservation in Female Cancer Patients

Inclusion Criteria: * Patients must be 14-42 year old females with a cancer diagnosis. * Clearance letter from treating oncologist. * Approval by program oncologist or her designee. * Informed consent has to be signed after consultation with the program physician. Minors require consent of a parent or a legal guardian and assent from the participant. * Life expectancy (predicted by their malignancy) of 5 or more years. * Cancer diagnosis should have an expected cure rate of 50% or more, based upon clinico-pathologic features. Exclusion Criteria: * Patients whose oncologist and the program oncologist concur that immediate oncologic care should be rendered, not allowing sufficient time for a course of gonadotropin therapy and egg retrieval. * FSH level \>20 MIU/ml, indicating abnormal ovarian function. * Patients with stage IV cancers (\*age appropriate women with stage IV advanced Hodgkin's Lymphoma will be considered, as there is a significant long term survival rate with this advanced disease). * Patients with incurable cancer diagnoses. * Patients who are unable or unwilling to sign the informed consent. * Women cannot have an embryo transfer beyond age 50.